TUESDAY, April 26, 2022 – The U.S. Food and Drug Administration on Tuesday approved the antiviral remdesivir as the first COVID-19 treatment for young children.
The drug had so far only been available to this age group under a special FDA emergency use authorization order. Now, doctors treating kids under 12 who are hospitalized or are at home with mild-to-moderate COVID but a high risk for severe COVID can readily prescribe Veklury to their young patients. Remdesivir had already been fully approved to treat people 12 and older.
"As COVID-19 can cause severe illness in children, some of whom do not currently have a vaccination option, there continues to be a need for safe and effective COVID-19 treatment options for this population," Dr. Patrizia Cavazzoni, director of the FDA's Center for Drug Evaluation and Research, said in an agency news release.
"Today's approval of the first COVID-19 therapeutic for this population demonstrates the agency's commitment to that need."“This approval means thatcan potentially provide meaningful clinical improvement, by reducing disease progression and helping children recover from COVID-19 more quickly,” said Dr. Amina Ahmed, from Atrium Health-Levine Children’s Hospital in Charlotte, N.C.
RemDeathSevere?
This BS has to stop!
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA approves COVID drug for children, China deals with uphill COVID battle, and more COVID newsThe US Food and Drug Administration announced Monday that it has expanded approval of the COVID-19 drug remdesivir to treat patients as young as 28 days old. Here's that and more COVID news.
Source: dothaneagle - 🏆 337. / 59 Read more »
Coronavirus: FDA approves first COVID-19 treatment for children younger than 12The FDA said Monday it expanded the approval of Veklury to include pediatric patients in certain circumstances.
Source: KIRO7Seattle - 🏆 271. / 63 Read more »
FDA approves first COVID-19 treatment for children under 12 years oldThe FDA gave approval to the use of Veklury (remdesivir) for children 28 days and older who weigh at least 3 kilograms (about 7 pounds).
Source: PennLive - 🏆 463. / 53 Read more »
Beto O’Rourke tests positive for COVID-19, experiencing mild symptomsBeto O’Rourke, the Democratic candidate for Texas governor, tested positive for COVID-19 on Monday. Stop with the COVID fear tactics. There is no reason for anyone to care about this headline - he is a healthy young person who is vaccinated. This isn't news, this is click bait that is hurting teenage minds and you are making people mentally ill so that you can make a buck. Stay home 7 days
Source: HoustonChron - 🏆 609. / 51 Read more »
COVID-19 has ‘strong affinity’ for damaging kidney cellsA new study published in FrontCellDevBio explains the connection between rising COVID-19 case counts in early 2020 and the growing number of kidney injuries - via healthing_ca healthing COVID19 news
Source: TheStarPhoenix - 🏆 253. / 63 Read more »
Mixing with unvaccinated increases COVID-19 risk for vaccinated people, study findsIn contrast, unvaccinated people’s risk of contracting COVID\u002D19 drops when they spend time with people who are vaccinated, because they serve as a buffer to…
Source: TheStarPhoenix - 🏆 253. / 63 Read more »